Sangamo BioSciences





Ebitda Zmiana Data
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.14B 775M 2025-12
Bayer EUR 1.51B 1.28B 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 1.96B 1.27B 2025-06
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
J&J USD 9.52B 389M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Merck USD 8.39B 1.97B 2025-09
Novartis USD 5.88B 290M 2025-09
Omeros USD -47.96M 7.39M 2023-09
Pfizer USD 6.08B 351M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Tectonic Therapeutic USD -13.48M 5.73M 2024-12
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Sangamo BioSciences - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.